Rapid dFLC Response Predict CHR in AL Amyloidosis

NCT06627309 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Systemic AL Amyloidosis

Interventions

DRUG: Dara IV
DRUG: Bortezomib (drug)
DRUG: Dexamethasone
DRUG: Cyclophosphamide (CTX)
DRUG: Dara SC

Sponsor

Peking University People's Hospital